Berkeley Lovelace Jr.

NBC News Clone summarizes the latest on: Berkeley Lovelace Jr Ncpn1284341 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.

Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.

Do you have a news tip you want to share with our journalists? Visit NBC News Tips to learn more.

Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.

Do you have a news tip you want to share with our journalists? Visit NBC News Tips to learn more.


Latest from Berkeley Lovelace Jr.

With Obamacare premium hikes, more people opting for no coverage or cheaper plans

More people appear to be walking away from ACA coverage or switching to cheaper plans for 2026 compared to this time last year, according to early enrollment data.

Insurance denied an $800,000 drug twice. A state-run outside panel helped a North Carolina teen get it.

When insurance twice refused to cover a nearly $800,000-a-year drug that Paxton Pope’s doctor believed could dramatically reduce his frequent seizures, his family initially braced for a serious medical setback.
6d ago

news

/

Kids' Health

news

/

Kids' Health

FDA launches safety review of two RSV drugs for infants as Kennedy scrutinizes immunizations

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary RFK, Jr.
10d ago

FDA chief says Biden administration withheld data on heart risk from Covid vaccines

The Biden administration withheld data from the public on the risks of myocarditis from the Covid vaccine, FDA Commissioner Marty Makary claimed Thursday.
11d ago

Novo Nordisk still sees potential for GLP-1 drugs for Alzheimer’s, despite trial setback

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing trials last month.
16d ago

FDA claims Covid shots killed 10 children and vows new vaccine rules

The director of the Food and Drug Administration’s vaccine division told agency staff in a memo that an internal review found that at least 10 children died “after and because of receiving” the Covid vaccine
19d ago

Medicare announces price cuts for 15 prescription drugs, including Ozempic

The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy.
25d ago

Pfizer's mRNA flu shot outperforms standard flu vaccine in late-stage trial

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine
27d ago

A record number of Americans are anxious about health care costs going into next year

Americans are going into 2026 more anxious about health care costs than at any other point in recent years, a new West Health-Gallup survey finds.
32d ago

What the government shutdown's end means for Obamacare subsidies

The government shutdown has ended, but Senate Democrats didn’t get a key provision they were fighting for: extending the Obamacare tax credits that are set to expire at the end of the year.
34d ago

Trump’s drug pricing push sidelines Medicare negotiation program

As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program.
×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone